Amarin Corp Plc\uk SEC filings AMRN
Amarin Corp Plc\uk has 1,003 filings in SEC EDGAR's recent list, going back to Feb 3, 2012. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 28, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Apr 10, 2026 | Apr 10, 2026 |
| PRE 14A | Preliminary proxy statement | Mar 30, 2026 | Mar 30, 2026 |
| DEF 14A | Proxy statement | Apr 10, 2025 | May 13, 2025 |
| PRE 14A | Preliminary proxy statement | Mar 28, 2025 | Mar 28, 2025 |
| DEF 14A | Proxy statement | Mar 4, 2024 | Apr 18, 2024 |
| PRE 14A | Preliminary proxy statement | Feb 12, 2024 | Feb 12, 2024 |
| DEFA14A | Additional proxy material | Jun 26, 2023 | — |
| DEFA14A | Additional proxy material | Jun 8, 2023 | — |
| DEF 14A | Proxy statement | May 26, 2023 | — |
| PRE 14A | Preliminary proxy statement | May 9, 2023 | — |
| DEFA14A | Additional proxy material | Feb 27, 2023 | — |
| DEFA14A | Additional proxy material | Feb 21, 2023 | — |
| DEFA14A | Additional proxy material | Feb 17, 2023 | — |
| DEFA14A | Additional proxy material | Feb 16, 2023 | — |
| DEFA14A | Additional proxy material | Feb 15, 2023 | — |
| DEFA14A | Additional proxy material | Feb 14, 2023 | — |
| DEFA14A | Additional proxy material | Feb 13, 2023 | — |
| DEFA14A | Additional proxy material | Feb 9, 2023 | — |
| DEFA14A | Additional proxy material | Feb 6, 2023 | — |
| DEFA14A | Additional proxy material | Feb 6, 2023 | — |
| DEFA14A | Additional proxy material | Feb 2, 2023 | — |
| DEFA14A | Additional proxy material | Jan 31, 2023 | — |
| DEFA14A | Additional proxy material | Jan 23, 2023 | — |
| DEFA14A | Additional proxy material | Jan 19, 2023 | — |
| DEFA14A | Additional proxy material | Jan 12, 2023 | — |
| DEFA14A | Additional proxy material | Jan 11, 2023 | — |
| DEFA14A | Additional proxy material | Oct 11, 2022 | — |
| DEFA14A | Additional proxy material | Jun 17, 2022 | — |
| DEF 14A | Proxy statement | May 24, 2022 | Jun 27, 2022 |
| DEF 14A | Proxy statement | Apr 29, 2021 | Jun 14, 2021 |
| DEF 14A | Proxy statement | Jun 1, 2020 | Jul 13, 2020 |
| DEF 14A | Proxy statement | Apr 25, 2019 | May 20, 2019 |
| PRE 14A | Preliminary proxy statement | Apr 15, 2019 | May 20, 2019 |
| DEF 14A | Proxy statement | Apr 20, 2018 | May 14, 2018 |
| DEF 14A | Proxy statement | Apr 21, 2017 | May 15, 2017 |
| DEF 14A | Proxy statement | Apr 29, 2016 | Jul 11, 2016 |
| DEF 14A | Proxy statement | Apr 24, 2015 | Jul 6, 2015 |
| PRE 14A | Preliminary proxy statement | Apr 3, 2015 | Jul 6, 2015 |
| DEF 14A | Proxy statement | Apr 30, 2014 | Jul 7, 2014 |
| DEF 14A | Proxy statement | Apr 23, 2013 | Jul 9, 2013 |
| PRE 14A | Preliminary proxy statement | Mar 25, 2013 | Jul 9, 2013 |
| DEF 14A | Proxy statement | Apr 27, 2012 | Jul 10, 2012 |
Showing 42 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AMRN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- United Kingdom
- Headquarters
- Dublin 2
- SEC filer status
- Accelerated filer
- SEC CIK
- 897448
- Former names
- AMARIN CORP PLC\UK (until Oct 28, 2026); AMARIN PHARMACEUTICALS PLC (until Jul 13, 2000); ETHICAL HOLDINGS PLC (until Jan 28, 1998)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.